Edmonton, Alberta, Canada/January 17, 2023 – Pacylex Pharmaceuticals, a clinical-stage company developing first-in-class therapies for leukemia, lymphoma, and solid tumor cancers, announced the appointment of Michele Libonati to the role of Chief Operating Officer (COO). In th...